Antibiotic Selection for Skin Infections
Treatment Algorithm Based on Infection Type
- The American College of Physicians and the Infectious Diseases Society of America recommend Augmentin (amoxicillin-clavulanate) as the first choice for mild, uncomplicated skin infections, providing optimal coverage for the most common pathogens, including penicillinase-resistant staphylococci and streptococci, with a response rate of 94% in primary skin sepsis, infected eczema, and infected trauma 1, 2
- For patients with beta-lactam allergy or intolerance, the IDSA recommends Clindamycin as the preferred alternative, with equivalent efficacy to TMP-SMX for uncomplicated skin infections (89.5% vs 88.2% cure rates) 1, 2, 3, 4
- Cefuroxime can be used but offers no advantage over Augmentin and has narrower anaerobic coverage, with no significant difference in treatment effect between penicillins and cephalosporins for cellulitis (RR 0.99; 95% CI 0.68-1.43) 1, 5
Comparative Strengths and Limitations
- Augmentin has the broadest spectrum against typical skin pathogens, including penicillinase-producing S. aureus, S. pyogenes, and anaerobes, but requires proper storage to avoid degradation 1
- Clindamycin is the best choice for MRSA coverage, suppressing bacterial toxin production, particularly valuable in toxin-mediated syndromes and necrotizing infections, but has a higher risk of Clostridioides difficile infection compared to beta-lactams 1, 2, 6
Common Pitfalls to Avoid
- The IDSA advises against using cefuroxime alone for polymicrobial infections involving anaerobes, and recommends adding metronidazole or clindamycin 3, 4
- The American College of Physicians warns against prescribing clindamycin empirically without considering local resistance patterns, as macrolide resistance can reach 18.3% in some regions, with cross-resistance to clindamycin 2
Special Populations
- For pediatric patients, the IDSA recommends Augmentin as first-line with dosing of 25-50 mg/kg/day divided into 3-4 doses, and Clindamycin dosing of 10-20 mg/kg/day in 3 divided doses 6
- For penicillin-allergic patients, the IDSA recommends Clindamycin as the preferred alternative, with Cefuroxime usable cautiously in non-severe penicillin allergy but avoided in immediate-type hypersensitivity 1, 3, 4, 6